Statins in patients with chronic kidney disease: why, who and when?-Reference-Cited by-同舟云学术

Statins in patients with chronic kidney disease: why, who and when?

Published:2010-10-27 Issue:16 Volume:11 Page:2665-2674
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Gluba Anna,Rysz Jacek,Banach Maciej

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14656566.2010.512419

Reference95 articles.

1. US Renal Data System. USRDS 2005 Annual Data Report, Bethesda, MD, The National Institute of Health, National Institute of Diabetes and Digestive Diseases; 2005

2. Pharmacokinetics of rosuvastatin in patients with end-stage kidney disease undergoing peritoneal dialysis

3. The evolving role of statins in the management of atherosclerosis

4. Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing dyslipidaemia in patients with chronic kidney disease;Indian Heart Journal;2024-03

2. Statin Therapy and Lipid Indices in Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Control Trials;Current Pharmaceutical Design;2024-02

3. Which Statin is Best for the Kidneys?;Current Vascular Pharmacology;2023-01

4. The effect of statins on all-cause and cardiovascular mortality in patients with non-dialysis chronic kidney disease, patients on dialysis, and kidney transplanted recipients: an umbrella review of meta-analyses;EUR REV MED PHARMACO;2021

5. Lipid-lowering agents for concurrent cardiovascular and chronic kidney disease;Expert Opinion on Pharmacotherapy;2019-08-06